These final results, together with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 support the strategy of focusing on ACKR3 as a singular technique to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-linked Problems. Identify your collection: https://isaacc469xbd4.blogpixi.com/profile